Page

Name

E-mail

Message

2026-02-26

#reports #ZVIA

[Zevia PBC](https://eninvs.com/all.php?name=ZVIA) (Beverages — Non-Alcoholic) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195122)
(2026-02-25, After Market Close):

- Revenue -2.6% YoY (vs +13.9% in previous quarter and historical rate +0.4%)
- EBITDA margin -2.6% increased compared to -15.4% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 7.4% of market cap
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-02-26

#reports #XPER

[Xperi](https://eninvs.com/all.php?name=XPER) (Semiconductor Equipment and Materials) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -4.1% YoY (vs -15.8% in previous quarter and historical rate -15.8%)
- EBITDA margin -8.5% increased compared to -9.0% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 2.8% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-02-26

#reports #XPEL

[XPEL](https://eninvs.com/all.php?name=XPEL) (Automotive surface protection products manufacturer) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +13% YoY (vs +10.6% in previous quarter and historical rate +14.0%)
- EBITDA +21.4% YoY (vs -10.0% in previous quarter and historical rate +7.1%)
- EBITDA margin 13.9% increased compared to 13.0% same period last year
- Net Debt increased by $20 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 21.1x compared to historical level (75th percentile) of 21.9x
- EV/Sales multiple is 3.1x

------------------------------------------------

2026-02-26

#reports #VECO

[Veeco Instruments](https://eninvs.com/all.php?name=VECO) (Semiconductor Equipment and Materials) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195118)
(2026-02-25, After Market Close):

- Revenue -9.3% YoY (vs -10.3% in previous quarter and historical rate +1.2%)
- EBITDA -50% YoY (vs -54.5% in previous quarter and historical rate -10.1%)
- EBITDA margin 2.4% decreased compared to 4.4% same period last year
- Net Debt decreased by $21 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.1% of market cap
- EV/EBITDA multiple is 31.6x compared to historical level (75th percentile) of 20.4x
- EV/Sales multiple is 2.6x

------------------------------------------------

2026-02-26

#reports #VCYT

[Veracyte](https://eninvs.com/all.php?name=VCYT) (Medical services provider) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +18.5% YoY (vs +13.8% in previous quarter and historical rate +20.3%)
- EBITDA +320% YoY (vs +55.6% in previous quarter)
- EBITDA margin 29.8% increased compared to 8.4% same period last year
- Net Debt decreased by $47 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 38.9x compared to historical level (75th percentile) of 74.5x
- EV/Sales multiple is 5.5x

------------------------------------------------

2026-02-26

#reports #UHS

[Universal Health Services](https://eninvs.com/all.php?name=UHS) (Medical services provider) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195116)
(2026-02-25, After Market Close):

- Revenue -19.3% YoY (vs +13.4% in previous quarter and historical rate +31.1%)
- EBITDA +4.2% YoY (vs +26.8% in previous quarter and historical rate +19.3%)
- EBITDA margin 11.6% increased compared to 9.0% same period last year
- Net Debt increased by $36 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.2 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 10.4x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-02-26

#reports #TPH

[Tri Pointe Homes](https://eninvs.com/all.php?name=TPH) (House builder ) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue -22.4% YoY (vs -25.7% in previous quarter and historical rate -4.3%)
- EBITDA -48.3% YoY (vs -53.2% in previous quarter and historical rate -7.3%)
- EBITDA margin 9.4% decreased compared to 14.1% same period last year
- Net Debt decreased by $381 mln over the past reporting period (13.2% of market cap)
- FCF (LTM) -$0.4 bln (negative), 12.4% of market cap
- EV/EBITDA multiple is 4.9x compared to historical level (75th percentile) of 5.7x
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-02-26

#reports #TDOC

[Teladoc Health](https://eninvs.com/all.php?name=TDOC) (Health care provider) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +0.3% YoY (vs -2.3% in previous quarter and historical rate +1.8%)
- EBITDA margin -5.1% increased compared to -6.7% same period last year
- Net Debt decreased by $58 mln over the past reporting period (10.2% of market cap)
- FCF (LTM) -$0 bln (negative), 5.3% of market cap
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-02-26

#reports #SRPT

[Sarepta Therapeutics](https://eninvs.com/all.php?name=SRPT) (Therapeutic developer) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +11.6% YoY (vs +40.7% in previous quarter and historical rate +35.0%)
- EBITDA margin -92.8% decreased compared to -7.1% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (54.9% of market cap)
- FCF (LTM) -$0.2 bln (negative), 9.7% of market cap
- EV/Sales multiple is 1.4x

------------------------------------------------

2026-02-26

#reports #SNPS

[Synopsys](https://eninvs.com/all.php?name=SNPS) (Electronics design technology provider) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195112)
(2026-02-25, After Market Close):

- Revenue +57.9% YoY (vs +55.0% in previous quarter and historical rate +16.2%)
- EBITDA -37.2% YoY (vs -18.4% in previous quarter and historical rate +4.0%)
- EBITDA margin 11.4% decreased compared to 28.6% same period last year
- Net Debt decreased by $12.7 bln since the start of the year (16.4% of market cap)
- EV/EBITDA multiple is 60.8x compared to historical level (75th percentile) of 51.9x
- EV/Sales multiple is 10x

------------------------------------------------

2026-02-26

#reports #SHOO

[Steven Madden](https://eninvs.com/all.php?name=SHOO) (Women`s shoes manufacturer) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +36.6% YoY (vs +11.9% in previous quarter and historical rate +7.9%)
- EBITDA -18% YoY (vs +18.2% in previous quarter and historical rate -8.8%)
- EBITDA margin 6.6% decreased compared to 11.1% same period last year
- Net Debt increased by $420 mln over the past reporting period (13.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/EBITDA multiple is 15.5x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-02-26

#reports #SDGR

[Schrodinger/United States](https://eninvs.com/all.php?name=SDGR) (Software developer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195111)
(2026-02-25, After Market Close):

- Revenue +62.2% YoY (vs +54.3% in previous quarter and historical rate +22.4%)
- EBITDA margin -76.7% increased compared to -178.4% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0 bln (positive), 4.2% of market cap
- EV/Sales multiple is 3.6x

------------------------------------------------

2026-02-26

#reports #RXST

[RxSight, Inc.](https://eninvs.com/all.php?name=RXST) (Medical Devices) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195110)
(2026-02-25, After Market Close):

- Revenue -17.5% YoY (vs -14.3% in previous quarter and historical rate +46.9%)
- EBITDA margin -30.3% decreased compared to -20.0% same period last year
- Net Debt decreased by $1 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 3.4% of market cap
- EV/Sales multiple is 0.3x

------------------------------------------------

2026-02-26

#reports #RXRX

[Recursion Pharmaceuticals, Inc.](https://eninvs.com/all.php?name=RXRX) (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195109)
(2026-02-25, Before Market Open):

- Revenue +227.3% YoY (vs +136.4% in previous quarter and historical rate +96.2%)
- EBITDA margin -300.0% increased compared to -881.8% same period last year
- Net Debt decreased by $716 mln over the past reporting period (29.6% of market cap)
- FCF (LTM) -$0.4 bln (negative), 16.2% of market cap
- EV/Sales multiple is 19.5x

------------------------------------------------

2026-02-26

#reports #RRGB

[Red Robin Gourmet Burgers](https://eninvs.com/all.php?name=RRGB) (Restaurant chain owner) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -5.6% YoY (vs -3.6% in previous quarter and historical rate -1.5%)
- EBITDA margin 3.0% increased compared to -7.4% same period last year
- Net Debt decreased by $11 mln over the past reporting period (15.6% of market cap)
- FCF (LTM) +$0 bln (positive), 59.8% of market cap
- EV/EBITDA multiple is 13.8x compared to historical level (75th percentile) of 55.5x
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-02-26

#reports #ROOT

[Root, Inc.](https://eninvs.com/all.php?name=ROOT) (Insurance — Property and Casualty) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +55.7% YoY (vs +67.7% in previous quarter and historical rate +70.0%)
- Net Income margin 1.3% increased compared to -2.4% same period last year
- P/E multiple is 23.3x compared to historical level (75th percentile) of 58.9x
- P/S multiple is 0.7x
- Price to book: 3.7x

------------------------------------------------

2026-02-26

#reports #PRCT

[PROCEPT BioRobotics Corporation](https://eninvs.com/all.php?name=PRCT) (Medical Devices) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +11.8% YoY (vs +43.1% in previous quarter and historical rate +62.5%)
- EBITDA margin -72.4% decreased compared to -64.7% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 2.7% of market cap
- EV/Sales multiple is 3.6x

------------------------------------------------

2026-02-26

#reports #PLAB

[Photronics](https://eninvs.com/all.php?name=PLAB) (Semiconductor Equipment and Materials) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +6.1% YoY (vs -75.1% in previous quarter and historical rate +11.6%)
- EBITDA +2.7% YoY (vs -82.9% in previous quarter and historical rate +7.8%)
- EBITDA margin 33.3% decreased compared to 34.4% same period last year
- Net Debt increased by $294 mln over the past reporting period (14.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 4.7x
- EV/Sales multiple is 2.1x

------------------------------------------------

2026-02-26

#reports #PEN

[Penumbra](https://eninvs.com/all.php?name=PEN) (Medical equipment manufacturer) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +21.8% YoY (vs +17.9% in previous quarter and historical rate +18.4%)
- EBITDA +33.3% YoY (vs +38.2% in previous quarter and historical rate +100.9%)
- EBITDA margin 16.6% increased compared to 15.2% same period last year
- Net Debt increased by $137 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.0% of market cap
- EV/EBITDA multiple is 68.8x compared to historical level (75th percentile) of 395.1x
- EV/Sales multiple is 10.1x

------------------------------------------------

2026-02-26

#reports #PEB

[Pebblebrook Hotel Trust](https://eninvs.com/all.php?name=PEB) (REIT — Hotel and Motel) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195103)
(2026-02-25, After Market Close):

- Revenue +3.3% YoY (vs -1.5% in previous quarter and historical rate -0.9%)
- EBITDA +82.9% YoY (vs -55.2% in previous quarter and historical rate +5.7%)
- EBITDA margin 18.3% increased compared to 10.4% same period last year
- Net Debt increased by $19 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/EBITDA multiple is 14.1x compared to historical level (75th percentile) of 15.5x
- EV/Sales multiple is 2.6x

------------------------------------------------

2026-02-26

#reports #OC

[Owens Corning](https://eninvs.com/all.php?name=OC) (Building products manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195102)
(2026-02-25, Before Market Open):

- Revenue -79% YoY (vs -11.9% in previous quarter and historical rate +12.1%)
- EBITDA -42.6% YoY (vs -114.6% in previous quarter and historical rate +1.0%)
- EBITDA margin 27.8% increased compared to 10.2% same period last year
- Net Debt increased by $39 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.5% of market cap
- EV/EBITDA multiple is 9.9x compared to historical level (75th percentile) of 7.9x
- EV/Sales multiple is 1.7x

------------------------------------------------

2026-02-26

#reports #NTNX

[Nutanix](https://eninvs.com/all.php?name=NTNX) (Software provider) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +28% YoY (vs +15.7% in previous quarter and historical rate +16.1%)
- EBITDA +85.5% YoY (vs +125.0% in previous quarter and historical rate +100.9%)
- EBITDA margin 14.1% increased compared to 9.7% same period last year
- Net Debt decreased by $309 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0.8 bln (positive), 8.1% of market cap
- EV/EBITDA multiple is 55.4x compared to historical level (75th percentile) of 138.5x
- EV/Sales multiple is 4x

------------------------------------------------

2026-02-26

#reports #NRDS

[NerdWallet, Inc.](https://eninvs.com/all.php?name=NRDS) (Credit Services) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195100)
(2026-02-25, After Market Close):

- Revenue +629% YoY (vs +358.2% in previous quarter and historical rate +51.7%)
- Net Income margin 2.5% increased compared to 0.6% same period last year
- P/E multiple is 18x compared to historical level (75th percentile) of 260x
- P/S multiple is 0.4x
- Price to book: 2.4x

------------------------------------------------

2026-02-26

#reports #NMRK

[Newmark](https://eninvs.com/all.php?name=NMRK) (Real Estate Services) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +13.3% YoY (vs +25.8% in previous quarter and historical rate +7.8%)
- EBITDA +14.1% YoY (vs +52.3% in previous quarter and historical rate +58.3%)
- EBITDA margin 16.9% increased compared to 16.8% same period last year
- Net Debt decreased by $79 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 8.6x compared to historical level (75th percentile) of 11.3x
- EV/Sales multiple is 1.1x

------------------------------------------------

2026-02-26

#reports #NGVT

[Ingevity Corporation](https://eninvs.com/all.php?name=NGVT) (Chemical materials producer ) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -31.5% YoY (vs -15.5% in previous quarter and historical rate +0.6%)
- EBITDA -756.3% YoY (vs -175.7% in previous quarter and historical rate -30.5%)
- EBITDA margin -41.2% decreased compared to 4.3% same period last year
- Net Debt decreased by $1.5 bln since the start of the year (56.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/Sales multiple is 1.9x

------------------------------------------------

2026-02-26

#reports #MGPI

[MGP Ingredients](https://eninvs.com/all.php?name=MGPI) (Liquor manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195097)
(2026-02-25, Before Market Open):

- Revenue -23.8% YoY (vs -18.6% in previous quarter and historical rate -10.9%)
- EBITDA margin -89.9% decreased compared to -10.5% same period last year
- Net Debt decreased by $22 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0 bln (positive), 9.0% of market cap
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-02-26

#reports #MEG

[Montrose Environmental Group](https://eninvs.com/all.php?name=MEG) (Waste Management) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +2.1% YoY (vs +25.7% in previous quarter and historical rate +15.4%)
- EBITDA margin 4.7% increased compared to -3.7% same period last year
- Net Debt decreased by $19 mln over the past reporting period (2.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 8.0% of market cap
- EV/EBITDA multiple is 34.2x compared to historical level (75th percentile) of 336.5x
- EV/Sales multiple is 2.6x

------------------------------------------------

2026-02-26

#reports #MDXG

[MiMedx Group](https://eninvs.com/all.php?name=MDXG) (Medical Devices) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195096)
(2026-02-25, After Market Close):

- Revenue +26.9% YoY (vs +35.7% in previous quarter and historical rate +16.3%)
- EBITDA +90.9% YoY (vs +100.0% in previous quarter and historical rate +84.6%)
- EBITDA margin 17.8% increased compared to 11.8% same period last year
- Net Debt decreased by $24 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0 bln (positive), 4.9% of market cap
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 28x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-02-26

#reports #LXU

[LSB Industries](https://eninvs.com/all.php?name=LXU) (Chemicals) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +22.2% YoY (vs +42.2% in previous quarter and historical rate -8.2%)
- EBITDA margin 3.6% increased compared to -20.0% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0 bln (negative), 1.3% of market cap
- EV/EBITDA multiple is 12.3x compared to historical level (75th percentile) of 21.8x
- EV/Sales multiple is 1.9x

------------------------------------------------

2026-02-26

#reports #LMAT

[LeMaitre Vascular](https://eninvs.com/all.php?name=LMAT) (Medical equipment manufacturer) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +14.3% YoY (vs +10.9% in previous quarter and historical rate +15.4%)
- EBITDA +40% YoY (vs +43.8% in previous quarter and historical rate +32.0%)
- EBITDA margin 32.8% increased compared to 26.8% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0 bln (positive), 2.2% of market cap
- EV/EBITDA multiple is 22.6x compared to historical level (75th percentile) of 34.3x
- EV/Sales multiple is 7.1x

------------------------------------------------

2026-02-26

#reports #LIVN

[LivaNova](https://eninvs.com/all.php?name=LIVN) (Medical Devices) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195095)
(2026-02-25, Before Market Open):

- Revenue +10.2% YoY (vs +12.6% in previous quarter and historical rate +27.0%)
- EBITDA +55.9% YoY (vs +94.6% in previous quarter and historical rate +60.6%)
- EBITDA margin 14.1% increased compared to 9.9% same period last year
- Net Debt decreased by $31 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.4 bln (positive), 11.6% of market cap
- EV/EBITDA multiple is 9.8x compared to historical level (75th percentile) of 327.9x
- EV/Sales multiple is 1.6x

------------------------------------------------

2026-02-26

#reports #LFST

[LifeStance Health Group, Inc.](https://eninvs.com/all.php?name=LFST) (Medical Care Facilities) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195094)
(2026-02-25, Before Market Open):

- Revenue +17.5% YoY (vs +16.3% in previous quarter and historical rate +18.4%)
- EBITDA +100% YoY (vs +40.0% in previous quarter and historical rate +107.5%)
- EBITDA margin 8.4% increased compared to 4.9% same period last year
- Net Debt decreased by $46 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 38.4x compared to historical level (75th percentile) of 73.1x
- EV/Sales multiple is 2.1x

------------------------------------------------

2026-02-26

#reports #LAW

[CS Disco, Inc.](https://eninvs.com/all.php?name=LAW) (Software — Application) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +10.8% YoY (vs +13.9% in previous quarter and historical rate +5.2%)
- EBITDA margin -17.1% increased compared to -18.9% same period last year
- Net Debt decreased by $2 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0 bln (negative), 3.6% of market cap
- EV/Sales multiple is 1.8x

------------------------------------------------

2026-02-26

#reports #IRWD

[Ironwood Pharmaceuticals](https://eninvs.com/all.php?name=IRWD) (Drug Manufacturers — Specialty and Generic) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue -47.3% YoY (vs +32.6% in previous quarter and historical rate -10.0%)
- EBITDA -26.3% YoY (vs +181.5% in previous quarter and historical rate -2.7%)
- EBITDA margin 145.8% increased compared to 104.4% same period last year
- Net Debt increased by $123 mln over the past reporting period (15.4% of market cap)
- FCF (LTM) +$0.3 bln (positive), 31.6% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 6.7x
- EV/Sales multiple is 4.7x

------------------------------------------------

2026-02-26

#reports #IONS

[Ionis Pharmaceuticals](https://eninvs.com/all.php?name=IONS) (Drug Developer) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue -10.6% YoY (vs +17.2% in previous quarter and historical rate +27.2%)
- EBITDA margin -103.9% decreased compared to -46.7% same period last year
- Net Debt increased by $115 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0.7 bln (negative), 6.5% of market cap
- EV/Sales multiple is 12.1x

------------------------------------------------

2026-02-26

#reports #IMCR

[Immunocore Holdings plc](https://eninvs.com/all.php?name=IMCR) (Biotechnology) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue -1.9% YoY (vs +15.9% in previous quarter and historical rate +97.0%)
- EBITDA margin -19.2% decreased compared to -17.9% same period last year
- Net Debt decreased by $370 mln over the past reporting period (20.9% of market cap)
- FCF (LTM) -$0.3 bln (negative), 17.1% of market cap
- EV/Sales multiple is 4.1x

------------------------------------------------

2026-02-26

#reports #HNST

[The Honest Company, Inc.](https://eninvs.com/all.php?name=HNST) (Specialty Retail) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -12% YoY (vs -6.1% in previous quarter and historical rate +6.2%)
- EBITDA -257.1% YoY (vs -85.7% in previous quarter)
- EBITDA margin -25.0% decreased compared to 14.0% same period last year
- Net Debt decreased by $20 mln over the past reporting period (7.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-02-26

#reports #HNI

[HNI Corporation](https://eninvs.com/all.php?name=HNI) (Business Equipment and Supplies) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +51% YoY (vs 0.0% in previous quarter and historical rate +9.2%)
- Net Income -372.2% YoY (vs 0.0% in previous quarter and historical rate +17.8%)
- Net Income margin -5.5% decreased compared to 3.1% same period last year
- P/E multiple is 34.7x compared to historical level (75th percentile) of 21.8x
- P/S multiple is 0.7x
- Price to book: 2.4x

------------------------------------------------

2026-02-26

#reports #HEI

[HEICO Corporation](https://eninvs.com/all.php?name=HEI) (Aerospace products manufacturer) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +31.6% YoY (vs +312.2% in previous quarter and historical rate +45.2%)
- EBITDA +38.2% YoY (vs +327.8% in previous quarter and historical rate +46.0%)
- EBITDA margin 26.4% increased compared to 25.1% same period last year
- Net Debt increased by $620 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.3 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 27.2x compared to historical level (75th percentile) of 32.6x
- EV/Sales multiple is 7.1x

------------------------------------------------

2026-02-26

#reports #HCI

[HCI Group](https://eninvs.com/all.php?name=HCI) (Insurance services provider) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +18.8% YoY (vs -0.6% in previous quarter and historical rate +23.4%)
- Net Income +89.5% YoY (vs -90.2% in previous quarter and historical rate +79.6%)
- Net Income margin 43.9% increased compared to 27.5% same period last year
- P/E multiple is 8.1x compared to historical level (75th percentile) of 12.5x
- P/S multiple is 1.8x
- Price to book: 1.8x

------------------------------------------------

2026-02-26

#reports #HBB

[Hamilton Beach Brands Company](https://eninvs.com/all.php?name=HBB) (Furnishings, Fixtures and Appliances) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195087)
(2026-02-25, After Market Close):

- Revenue -0.5% YoY (vs -15.3% in previous quarter and historical rate -1.9%)
- EBITDA +12% YoY (vs -66.7% in previous quarter and historical rate +19.6%)
- EBITDA margin 13.1% increased compared to 11.7% same period last year
- Net Debt decreased by $31 mln over the past reporting period (12.0% of market cap)
- FCF (LTM) -$0 bln (negative), 10.5% of market cap
- EV/EBITDA multiple is 7x compared to historical level (75th percentile) of 10.5x
- EV/Sales multiple is 0.5x

------------------------------------------------

2026-02-26

#reports #HAYW

[Hayward Holdings, Inc.](https://eninvs.com/all.php?name=HAYW) (Electrical Equipment and Parts) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +6.7% YoY (vs +7.0% in previous quarter and historical rate -2.6%)
- EBITDA +13.4% YoY (vs +23.4% in previous quarter and historical rate +1.8%)
- EBITDA margin 31.5% increased compared to 29.7% same period last year
- Net Debt increased by $45 mln over the past reporting period (1.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 5.9% of market cap
- EV/EBITDA multiple is 14.2x compared to historical level (75th percentile) of 17.6x
- EV/Sales multiple is 3.7x

------------------------------------------------

2026-02-26

#reports #GDRX

[GoodRx](https://eninvs.com/all.php?name=GDRX) (Digital healthcare platform) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -2% YoY (vs +0.5% in previous quarter and historical rate +1.5%)
- EBITDA +75.7% YoY (vs +10.5% in previous quarter and historical rate +49.0%)
- EBITDA margin 33.3% increased compared to 18.6% same period last year
- Net Debt increased by $9 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 20.6% of market cap
- EV/EBITDA multiple is 6.6x compared to historical level (75th percentile) of 38.7x
- EV/Sales multiple is 1.4x

------------------------------------------------

2026-02-26

#reports #FSS

[Federal Signal Corporation](https://eninvs.com/all.php?name=FSS) (Alarm system/sweeper manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195083)
(2026-02-25, Before Market Open):

- Revenue +33.3% YoY (vs +6.3% in previous quarter and historical rate +17.9%)
- EBITDA +36.4% YoY (vs +19.2% in previous quarter and historical rate +31.2%)
- EBITDA margin 17.6% increased compared to 17.2% same period last year
- Net Debt increased by $345 mln over the past reporting period (5.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 20.3x compared to historical level (75th percentile) of 19.5x
- EV/Sales multiple is 3.8x

------------------------------------------------

2026-02-26

#reports #EE

[Excelerate Energy, Inc.](https://eninvs.com/all.php?name=EE) (Utilities — Renewable) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +15.6% YoY (vs +102.6% in previous quarter and historical rate -8.2%)
- EBITDA +24.1% YoY (vs +43.4% in previous quarter and historical rate +20.0%)
- EBITDA margin 32.4% increased compared to 30.2% same period last year
- Net Debt decreased by $67 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0.9 bln (negative), 25.1% of market cap
- EV/EBITDA multiple is 16.4x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 5.1x

------------------------------------------------

2026-02-26

#reports #ECPG

[Encore Capital](https://eninvs.com/all.php?name=ECPG) (Financial services provider) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195081)
(2026-02-25, After Market Close):

- Revenue +44.5% YoY (vs -4.0% in previous quarter and historical rate -2.6%)
- Net Income +234.8% YoY (vs -22600.0% in previous quarter and historical rate -14.9%)
- Net Income margin 16.2% increased compared to 7.0% same period last year
- P/S multiple is 0.9x
- Price to book: 1.4x

------------------------------------------------

2026-02-26

#reports #CWT

[California Water Service Group](https://eninvs.com/all.php?name=CWT) (Water utility services provider ) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -70.1% YoY (vs +3.7% in previous quarter and historical rate +16.4%)
- EBITDA -72.7% YoY (vs +7.0% in previous quarter and historical rate +22.3%)
- EBITDA margin 28.2% decreased compared to 30.8% same period last year
- Net Debt increased by $77 mln over the past reporting period (2.9% of market cap)
- FCF (LTM) -$0.2 bln (negative), 5.7% of market cap
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 15.4x
- EV/Sales multiple is 4.3x

------------------------------------------------

2026-02-26

#reports #CPRX

[Catalyst Pharmaceuticals](https://eninvs.com/all.php?name=CPRX) (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195079)
(2026-02-25, After Market Close):

- Revenue +7.7% YoY (vs +14.7% in previous quarter and historical rate +43.8%)
- EBITDA -1.6% YoY (vs +29.4% in previous quarter and historical rate +35.8%)
- EBITDA margin 40.5% decreased compared to 44.4% same period last year
- Net Debt decreased by $20 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.2 bln (positive), 5.9% of market cap
- EV/EBITDA multiple is 8.7x compared to historical level (75th percentile) of 17.9x
- EV/Sales multiple is 3.8x

------------------------------------------------

2026-02-26

#reports #CPK

[Chesapeake Utilities Corporation](https://eninvs.com/all.php?name=CPK) (Utilities — Regulated Gas) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195078)
(2026-02-25, After Market Close):

- Revenue +20.5% YoY (vs +12.5% in previous quarter and historical rate +11.5%)
- EBITDA +21% YoY (vs +17.2% in previous quarter and historical rate +25.6%)
- EBITDA margin 37.8% increased compared to 37.7% same period last year
- Net Debt increased by $53 mln over the past reporting period (1.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 3.3% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 15.6x
- EV/Sales multiple is 5x

------------------------------------------------

2026-02-26

#reports #CHDN

[Churchill Downs](https://eninvs.com/all.php?name=CHDN) (Horse racing organizer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195077)
(2026-02-25, After Market Close):

- Revenue +6.7% YoY (vs +8.6% in previous quarter and historical rate +41.7%)
- EBITDA +25.1% YoY (vs +29.0% in previous quarter and historical rate +48.7%)
- EBITDA margin 42.6% increased compared to 36.4% same period last year
- Net Debt increased by $6 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.7% of market cap
- EV/EBITDA multiple is 7.7x compared to historical level (75th percentile) of 14.8x
- EV/Sales multiple is 3x

------------------------------------------------

2026-02-26

#reports #CBZ

[CBIZ](https://eninvs.com/all.php?name=CBZ) (Financial and insurance services provider) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +65.5% YoY (vs +6.8% in previous quarter and historical rate +20.5%)
- Net Income margin -14.5% decreased compared to -5.2% same period last year
- P/E multiple is 17.4x compared to historical level (75th percentile) of 23.5x
- P/S multiple is 1.3x
- Price to book: 1x

------------------------------------------------

2026-02-26

#reports #BLMN

[Bloomin Brands](https://eninvs.com/all.php?name=BLMN) (Restaurants owner) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +0.3% YoY (vs -10.6% in previous quarter and historical rate -3.3%)
- EBITDA -49.2% YoY (vs -86.6% in previous quarter and historical rate -32.7%)
- EBITDA margin 3.2% decreased compared to 6.3% same period last year
- Net Debt increased by $7 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 2.3x compared to historical level (75th percentile) of 3x
- EV/Sales multiple is 0.1x

------------------------------------------------

2026-02-26

#reports #BJRI

[BJs Restaurants](https://eninvs.com/all.php?name=BJRI) (Restaurants owner) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +9.6% YoY (vs +2.2% in previous quarter and historical rate +8.7%)
- EBITDA +47.6% YoY (vs +6.7% in previous quarter and historical rate +11.7%)
- EBITDA margin 8.7% increased compared to 6.5% same period last year
- Net Debt decreased by $507 mln over the past reporting period (57.0% of market cap)
- FCF (LTM) -$0.5 bln (negative), 57.5% of market cap
- EV/EBITDA multiple is 8.3x compared to historical level (75th percentile) of 13.9x
- EV/Sales multiple is 0.6x

------------------------------------------------

2026-02-26

#reports #BBSI

[Barrett Business Services](https://eninvs.com/all.php?name=BBSI) (Platform for the provision of consulting services) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +5.2% YoY (vs +8.5% in previous quarter and historical rate +5.7%)
- EBITDA -8.7% YoY (vs +8.0% in previous quarter and historical rate -7.0%)
- EBITDA margin 6.5% decreased compared to 7.5% same period last year
- Net Debt decreased by $48 mln over the past reporting period (5.0% of market cap)
- FCF (LTM) -$0 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 14.5x
- EV/Sales multiple is 0.7x

------------------------------------------------

2026-02-26

#reports #ASTE

[Astec Industries](https://eninvs.com/all.php?name=ASTE) (Road construction equipment supplier) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +11.7% YoY (vs +20.3% in previous quarter and historical rate +3.8%)
- EBITDA -26.1% YoY (vs 0.0% in previous quarter and historical rate +58.1%)
- EBITDA margin 8.5% decreased compared to 12.8% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.2 bln (negative), 21.5% of market cap
- EV/EBITDA multiple is 15x compared to historical level (75th percentile) of 22x
- EV/Sales multiple is 1x

------------------------------------------------

2026-02-26

#reports #ASPN

[Aspen Aerogels](https://eninvs.com/all.php?name=ASPN) (Building Products and Equipment) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue -66.7% YoY (vs -37.6% in previous quarter and historical rate +30.5%)
- EBITDA -500% YoY (vs -90.9% in previous quarter and historical rate +34.4%)
- EBITDA margin -165.9% decreased compared to 13.8% same period last year
- Net Debt decreased by $12 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 33.9% of market cap
- EV/Sales multiple is 1x

------------------------------------------------

2026-02-26

#reports #AOMR

[Angel Oak Mortgage, Inc.](https://eninvs.com/all.php?name=AOMR) (REIT — Mortgage) reported for 2025 q4
(2026-02-25, Before Market Open):

- Revenue +10% YoY (vs +11.1% in previous quarter and historical rate +45.7%)
- EBITDA +25% YoY (vs -7600.0% in previous quarter and historical rate +4.9%)
- EBITDA margin 45.5% increased compared to 40.0% same period last year
- Net Debt decreased by $112 mln over the past reporting period (50.3% of market cap)
- FCF (LTM) -$0.2 bln (negative), 110.1% of market cap
- EV/Sales multiple is 12x

------------------------------------------------

2026-02-26

#reports #AMSF

[AMERISAFE](https://eninvs.com/all.php?name=AMSF) (Insurance services provider) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +2.5% YoY (vs -7.5% in previous quarter and historical rate +0.7%)
- Net Income -41.2% YoY (vs -31.6% in previous quarter and historical rate +9.2%)
- Net Income margin 12.2% decreased compared to 21.3% same period last year
- P/E multiple is 14.8x compared to historical level (75th percentile) of 16.4x
- P/S multiple is 2.3x
- Price to book: 2.6x

------------------------------------------------

2026-02-26

#reports #ALKT

[Alkami Technology, Inc.](https://eninvs.com/all.php?name=ALKT) (Software — Application) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +70.4% YoY (vs +26.5% in previous quarter and historical rate +33.8%)
- EBITDA margin 11.6% increased compared to -14.1% same period last year
- Net Debt increased by $354 mln over the past reporting period (18.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.5% of market cap
- EV/Sales multiple is 6.1x

------------------------------------------------

2026-02-26

#reports #ALKS

[Alkermes](https://eninvs.com/all.php?name=ALKS) (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195071)
(2026-02-25, Before Market Open):

- Revenue -10.5% YoY (vs +4.2% in previous quarter and historical rate +15.0%)
- EBITDA -80.2% YoY (vs -69.6% in previous quarter and historical rate +70.2%)
- EBITDA margin 15.1% decreased compared to 68.1% same period last year
- Net Debt decreased by $44 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.3 bln (negative), 5.1% of market cap
- EV/EBITDA multiple is 39x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 3.3x

------------------------------------------------

2026-02-26

#reports #AGL

[agilon health, inc.](https://eninvs.com/all.php?name=AGL) (Medical Care Facilities) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +3.1% YoY (vs -1.1% in previous quarter and historical rate +33.2%)
- EBITDA margin -11.9% decreased compared to -6.7% same period last year
- Net Debt increased by $26 mln over the past reporting period (6.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 22.6% of market cap
- EV/Sales multiple is 0x

------------------------------------------------

2026-02-26

#reports #ADMA

[ADMA Biologics](https://eninvs.com/all.php?name=ADMA) (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195067)
(2026-02-25, After Market Close):

- Revenue +87.8% YoY (vs +79.1% in previous quarter and historical rate +88.3%)
- EBITDA +293.8% YoY (vs +281.8% in previous quarter and historical rate +116.7%)
- EBITDA margin 45.3% increased compared to 21.6% same period last year
- Net Debt decreased by $39 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 23.5x compared to historical level (75th percentile) of 45x
- EV/Sales multiple is 9x

------------------------------------------------

2026-02-26

#reports #ACAD

[ACADIA Pharmaceuticals](https://eninvs.com/all.php?name=ACAD) (Medicines manufacturer) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +9.2% YoY (vs +11.6% in previous quarter and historical rate +29.8%)
- EBITDA -86.6% YoY (vs +12.5% in previous quarter and historical rate +95.8%)
- EBITDA margin 7.4% decreased compared to 60.4% same period last year
- Net Debt increased by $25 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.0% of market cap
- EV/EBITDA multiple is 34.6x compared to historical level (75th percentile) of 66.4x
- EV/Sales multiple is 3.5x

------------------------------------------------

2026-02-26

#reports #A

[Agilent Technologies](https://eninvs.com/all.php?name=A) (Core bio-analytical and electronic measurement solutions provider ) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +7% YoY (vs -44.6% in previous quarter and historical rate +4.6%)
- EBITDA -6.3% YoY (vs -32.3% in previous quarter and historical rate +0.9%)
- EBITDA margin 23.4% decreased compared to 26.7% same period last year
- Net Debt increased by $31 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.7 bln (positive), 1.7% of market cap
- EV/EBITDA multiple is 24.7x compared to historical level (75th percentile) of 24.3x
- EV/Sales multiple is 5.9x

------------------------------------------------

2026-02-26

#reports #SNOW
@ saas

[Snowflake](https://eninvs.com/all.php?name=SNOW) (Cloud-based data storage and analytics service) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +30.1% YoY (vs +28.8% in previous quarter and historical rate +31.7%)
- EBITDA margin -25.9% increased compared to -40.3% same period last year
- Net Debt decreased by $622 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0.7 bln (negative), 1.0% of market cap
- EV/Sales multiple is 14.2x

------------------------------------------------

2026-02-26

#reports #ARRY
@ renewable-energy

[Array Technologies](https://eninvs.com/all.php?name=ARRY) (Utility-scale solar tracker technology provider) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -17.8% YoY (vs +70.1% in previous quarter and historical rate +2.2%)
- EBITDA margin -58.4% decreased compared to -47.3% same period last year
- Net Debt decreased by $479 mln over the past reporting period (28.1% of market cap)
- FCF (LTM) +$0.3 bln (positive), 17.0% of market cap
- EV/EBITDA multiple is 112.4x compared to historical level (75th percentile) of 45.1x
- EV/Sales multiple is 1.7x

------------------------------------------------

2026-02-26

#reports #VICI
@ REITs

[VICI Properties](https://eninvs.com/all.php?name=VICI) (REIT — Diversified) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +3.8% YoY (vs +4.4% in previous quarter and historical rate +19.2%)
- EBITDA -2% YoY (vs +3.4% in previous quarter and historical rate +49.0%)
- EBITDA margin 80.5% decreased compared to 85.2% same period last year
- Net Debt decreased by $89 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 17x
- EV/Sales multiple is 11.7x

------------------------------------------------

2026-02-26

#reports #OUT
@ REITs

[Outfront Media (REIT)](https://eninvs.com/all.php?name=OUT) (REIT — Specialty) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +4.1% YoY (vs +3.5% in previous quarter and historical rate +1.2%)
- EBITDA +14.8% YoY (vs -22.2% in previous quarter and historical rate -5.6%)
- EBITDA margin 30.2% increased compared to 27.4% same period last year
- Net Debt decreased by $134 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 2.2% of market cap
- EV/EBITDA multiple is 21.2x compared to historical level (75th percentile) of 18x
- EV/Sales multiple is 4.4x

------------------------------------------------

2026-02-26

#reports #EPR
@ REITs

[EPR Properties](https://eninvs.com/all.php?name=EPR) (REIT — Retail) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +3.4% YoY (vs +0.6% in previous quarter and historical rate +3.2%)
- EBITDA +70.9% YoY (vs +2.9% in previous quarter and historical rate +12.9%)
- EBITDA margin 80.3% increased compared to 48.6% same period last year
- Net Debt decreased by $17 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0 bln (negative), 0.7% of market cap
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 9.1x
- EV/Sales multiple is 6.5x

------------------------------------------------

2026-02-26

#reports #AI
@ REITs

[C3.ai](https://eninvs.com/all.php?name=AI) (Software provider ) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue -46.5% YoY (vs -58.8% in previous quarter and historical rate +13.6%)
- EBITDA margin -258.5% decreased compared to -81.8% same period last year
- Net Debt increased by $53 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) -$0 bln (negative), 2.8% of market cap
- EV/Sales multiple is 3.6x

------------------------------------------------

2026-02-26

#reports #ZM
@ cloud-computing , @ saas

[Zoom Video Communications](https://eninvs.com/all.php?name=ZM) (Group video conferencing platform) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +5.3% YoY (vs +4.4% in previous quarter and historical rate +3.5%)
- EBITDA +7.8% YoY (vs +47.6% in previous quarter and historical rate +55.8%)
- EBITDA margin 27.8% increased compared to 27.2% same period last year
- Net Debt increased by $129 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 13.7x compared to historical level (75th percentile) of 24.7x
- EV/Sales multiple is 4.2x

------------------------------------------------

2026-02-26

#reports #TTD
@ adtech , @ artificial-intelligence

[Trade Desk](https://eninvs.com/all.php?name=TTD) (Marketing services provider ) reported for 2025 q4
(2026-02-25, After Market Close):

- Revenue +14.3% YoY (vs +17.7% in previous quarter and historical rate +22.7%)
- EBITDA +33.7% YoY (vs +47.3% in previous quarter and historical rate +77.0%)
- EBITDA margin 41.2% increased compared to 35.2% same period last year
- Net Debt increased by $202 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0.2 bln (negative), 0.9% of market cap
- EV/EBITDA multiple is 19.4x compared to historical level (75th percentile) of 150x
- EV/Sales multiple is 5.3x

------------------------------------------------

2026-02-25

#reports #ZETA

[Zeta Global Holdings Corp.](https://eninvs.com/all.php?name=ZETA) (Software — Application) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +25.4% YoY (vs +25.7% in previous quarter and historical rate +30.4%)
- EBITDA +58.3% YoY (vs +800.0% in previous quarter and historical rate +71.5%)
- EBITDA margin 9.6% increased compared to 7.6% same period last year
- Net Debt increased by $65 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 57.1x compared to historical level (75th percentile) of 2625x
- EV/Sales multiple is 3.4x

------------------------------------------------

2026-02-25

#reports #XMTR

[Xometry, Inc.](https://eninvs.com/all.php?name=XMTR) (Specialty Industrial Machinery) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195066)
(2026-02-24, Before Market Open):

- Revenue +28.9% YoY (vs +27.5% in previous quarter and historical rate +21.7%)
- EBITDA margin -2.1% increased compared to -5.4% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.7% of market cap
- EV/Sales multiple is 4.9x

------------------------------------------------

2026-02-25

#reports #WLKP

[Westlake Chemical Partners LP](https://eninvs.com/all.php?name=WLKP) (Chemicals) reported for 2025 q4
(2026-02-24, Before Market Open):

- Revenue +11.4% YoY (vs +11.6% in previous quarter and historical rate -8.6%)
- EBITDA -2.5% YoY (vs -28.3% in previous quarter and historical rate +12.2%)
- EBITDA margin 36.5% decreased compared to 41.7% same period last year
- Net Debt increased by $537 mln over the past reporting period (72.1% of market cap)
- FCF (LTM) +$0.6 bln (positive), 73.9% of market cap
- EV/EBITDA multiple is 5x compared to historical level (75th percentile) of 4.3x
- EV/Sales multiple is 1.4x

------------------------------------------------

2026-02-25

#reports #WLK

[Westlake Chemical Corporation](https://eninvs.com/all.php?name=WLK) (Chemicals and building materials manufacturer) reported for 2025 q4
(2026-02-24, Before Market Open):

- Revenue -10.4% YoY (vs +0.1% in previous quarter and historical rate +4.1%)
- EBITDA -395.6% YoY (vs -26.0% in previous quarter and historical rate -24.3%)
- EBITDA margin -26.5% decreased compared to 8.0% same period last year
- Net Debt increased by $932 mln over the past reporting period (8.6% of market cap)
- FCF (LTM) -$0.6 bln (negative), 5.9% of market cap
- EV/EBITDA multiple is 13.8x compared to historical level (75th percentile) of 8.8x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-02-25

#reports #VRRM

[Verra Mobility](https://eninvs.com/all.php?name=VRRM) (Security and Protection Services) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195064)
(2026-02-24, After Market Close):

- Revenue +16.2% YoY (vs +15.9% in previous quarter and historical rate +9.8%)
- EBITDA margin 27.9% increased compared to -7.2% same period last year
- Net Debt increased by $130 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.7% of market cap
- EV/EBITDA multiple is 12x compared to historical level (75th percentile) of 18.2x
- EV/Sales multiple is 4.3x

------------------------------------------------

2026-02-25

#reports #UVE

[Universal Insurance](https://eninvs.com/all.php?name=UVE) (Insurance — Property and Casualty) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +20% YoY (vs +16.1% in previous quarter and historical rate +19.1%)
- Net Income +131% YoY (vs +41.7% in previous quarter and historical rate +39.7%)
- Net Income margin 16.4% increased compared to 8.5% same period last year
- P/E multiple is 8x compared to historical level (75th percentile) of 11.3x
- P/S multiple is 0.6x
- Price to book: 1.9x

------------------------------------------------

2026-02-25

#reports #UFPT

[UFP Technologies](https://eninvs.com/all.php?name=UFPT) (Medical Devices) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +3.5% YoY (vs +6.9% in previous quarter and historical rate +20.9%)
- EBITDA -4% YoY (vs -6.7% in previous quarter and historical rate +24.7%)
- EBITDA margin 16.1% decreased compared to 17.4% same period last year
- Net Debt decreased by $13 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 2.5% of market cap
- EV/EBITDA multiple is 19.6x compared to historical level (75th percentile) of 25.8x
- EV/Sales multiple is 3.4x

------------------------------------------------

2026-02-25

#reports #TREX

[Trex Company](https://eninvs.com/all.php?name=TREX) (Wood and plastic products manufacturer ) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue -17.9% YoY (vs -23.0% in previous quarter and historical rate +2.4%)
- EBITDA -51.2% YoY (vs -31.3% in previous quarter and historical rate +16.1%)
- EBITDA margin 12.4% decreased compared to 20.9% same period last year
- Net Debt increased by $78 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$1.5 bln (positive), 33.6% of market cap
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 28.3x
- EV/Sales multiple is 4.1x

------------------------------------------------

2026-02-25

#reports #TMDX

[TransMedics Group](https://eninvs.com/all.php?name=TMDX) (Medical Devices) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195063)
(2026-02-24, After Market Close):

- Revenue +32% YoY (vs +32.1% in previous quarter and historical rate +95.1%)
- EBITDA +70.6% YoY (vs +100.0% in previous quarter and historical rate +130.9%)
- EBITDA margin 18.0% increased compared to 13.9% same period last year
- Net Debt decreased by $22 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 35.1x compared to historical level (75th percentile) of 62.7x
- EV/Sales multiple is 7.9x

------------------------------------------------

2026-02-25

#reports #SUPN

[Supernus Pharmaceuticals](https://eninvs.com/all.php?name=SUPN) (Pharmaceutical manufacturer) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue -33.3% YoY (vs +9.1% in previous quarter and historical rate +5.8%)
- EBITDA -47.2% YoY (vs -153.0% in previous quarter and historical rate +10.2%)
- EBITDA margin 13.2% decreased compared to 16.7% same period last year
- Net Debt decreased by $28 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 6.2% of market cap
- EV/EBITDA multiple is 74.7x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 3.5x

------------------------------------------------

2026-02-25

#reports #SHLS

[Shoals Technologies Group, Inc.](https://eninvs.com/all.php?name=SHLS) (Solar) reported for 2025 q4
(2026-02-24, Before Market Open):

- Revenue +38.3% YoY (vs +33.3% in previous quarter and historical rate +16.9%)
- EBITDA +5% YoY (vs +175.0% in previous quarter and historical rate +30.8%)
- EBITDA margin 14.2% decreased compared to 18.7% same period last year
- Net Debt increased by $11 mln over the past reporting period (0.7% of market cap)
- EV/EBITDA multiple is 24x compared to historical level (75th percentile) of 31.7x
- EV/Sales multiple is 3.5x

------------------------------------------------

2026-02-25

#reports #SAM

[The Boston Beer Company](https://eninvs.com/all.php?name=SAM) (Alcoholic beverages supplier) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195060)
(2026-02-23, After Market Close):

- Revenue +53.5% YoY (vs -16.4% in previous quarter and historical rate +0.8%)
- EBITDA margin -2.0% increased compared to -10.0% same period last year
- Net Debt increased by $24 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.1% of market cap
- EV/EBITDA multiple is 10.6x compared to historical level (75th percentile) of 21.1x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-02-25

#reports #RVLV

[Revolve Group](https://eninvs.com/all.php?name=RVLV) (E-commerce fashion company) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +10.2% YoY (vs +4.6% in previous quarter and historical rate +3.9%)
- EBITDA +69.2% YoY (vs +43.8% in previous quarter and historical rate +32.4%)
- EBITDA margin 6.8% increased compared to 4.4% same period last year
- Net Debt increased by $20 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.0% of market cap
- EV/EBITDA multiple is 23.2x compared to historical level (75th percentile) of 40.3x
- EV/Sales multiple is 1.5x

------------------------------------------------

2026-02-25

#reports #RGEN

[Repligen](https://eninvs.com/all.php?name=RGEN) (Highly innovative biotechnological technologies developer) reported for 2025 q4
(2026-02-24, Before Market Open):

- Revenue +17.9% YoY (vs +21.9% in previous quarter and historical rate -1.2%)
- EBITDA margin 25.8% increased compared to -22.0% same period last year
- Net Debt increased by $671 mln over the past reporting period (7.3% of market cap)
- FCF (LTM) +$0.7 bln (positive), 8.0% of market cap
- EV/EBITDA multiple is 67.1x compared to historical level (75th percentile) of 178.6x
- EV/Sales multiple is 12.4x

------------------------------------------------

2026-02-25

#reports #REZI

[Resideo Technologies](https://eninvs.com/all.php?name=REZI) (Smart home device manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195058)
(2026-02-24, After Market Close):

- Revenue -43.5% YoY (vs +17.6% in previous quarter and historical rate +22.1%)
- EBITDA -14.1% YoY (vs -10.7% in previous quarter and historical rate +15.2%)
- EBITDA margin 10.0% increased compared to 6.6% same period last year
- Net Debt increased by $1.5 bln since the start of the year (28.7% of market cap)
- FCF (LTM) -$0.7 bln (negative), 14.3% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 7.9x
- EV/Sales multiple is 1.2x

------------------------------------------------

2026-02-25

#reports #RCKY

[Rocky Brands](https://eninvs.com/all.php?name=RCKY) (Footwear and Accessories) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +9.4% YoY (vs +7.0% in previous quarter and historical rate -6.4%)
- EBITDA +12.5% YoY (vs +14.3% in previous quarter and historical rate +12.3%)
- EBITDA margin 6.4% increased compared to 6.3% same period last year
- Net Debt decreased by $17 mln over the past reporting period (7.0% of market cap)
- FCF (LTM) -$0 bln (negative), 3.7% of market cap
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 0.8x

------------------------------------------------

2026-02-25

#reports #PLNT

[Planet Fitness](https://eninvs.com/all.php?name=PLNT) ( Fitness centers owner) reported for 2025 q4
(2026-02-24, Before Market Open):

- Revenue +10.6% YoY (vs +13.0% in previous quarter and historical rate +12.6%)
- EBITDA +12.3% YoY (vs +19.7% in previous quarter and historical rate +33.1%)
- EBITDA margin 38.8% increased compared to 38.2% same period last year
- Net Debt increased by $314 mln over the past reporting period (4.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 17.7x compared to historical level (75th percentile) of 22.1x
- EV/Sales multiple is 7.3x

------------------------------------------------

2026-02-25

#reports #NRG

[NRG Energy](https://eninvs.com/all.php?name=NRG) (Energy services provider) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195053)
(2026-02-24, Before Market Open):

- Revenue +132.4% YoY (vs +5.7% in previous quarter and historical rate +6.2%)
- EBITDA -71.4% YoY (vs +77300.0% in previous quarter and historical rate +33.4%)
- EBITDA margin 1.9% decreased compared to 15.2% same period last year
- Net Debt increased by $547 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$1.9 bln (negative), 5.3% of market cap
- EV/EBITDA multiple is 17x compared to historical level (75th percentile) of 14.5x
- EV/Sales multiple is 1.3x

------------------------------------------------

2026-02-25

#reports #MQ

[Marqeta, Inc.](https://eninvs.com/all.php?name=MQ) (Software — Infrastructure) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +26.5% YoY (vs +27.3% in previous quarter and historical rate +0.1%)
- EBITDA margin 7.6% increased compared to -23.5% same period last year
- Net Debt increased by $60 mln over the past reporting period (3.0% of market cap)
- FCF (LTM) -$0.2 bln (negative), 8.4% of market cap
- EV/EBITDA multiple is 1212.8x compared to historical level (75th percentile) of 20.2x
- EV/Sales multiple is 1.9x

------------------------------------------------

2026-02-25

#reports #MMSI

[Merit Medical Systems](https://eninvs.com/all.php?name=MMSI) (Medical instrument manufacturer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195050)
(2026-02-24, After Market Close):

- Revenue +11% YoY (vs +12.9% in previous quarter and historical rate +9.6%)
- EBITDA +32.3% YoY (vs +15.6% in previous quarter and historical rate +25.1%)
- EBITDA margin 21.8% increased compared to 18.3% same period last year
- Net Debt decreased by $53 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 17.1x compared to historical level (75th percentile) of 23.9x
- EV/Sales multiple is 3.5x

------------------------------------------------

2026-02-25

#reports #MGEE

[MGE Energy](https://eninvs.com/all.php?name=MGEE) (Utilities — Diversified) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195017)
(2026-02-25, After Market Close):

- Revenue +15.2% YoY (vs +4.3% in previous quarter and historical rate +23.8%)
- EBITDA -44.8% YoY (vs +70.2% in previous quarter and historical rate +10.9%)
- EBITDA margin 16.8% decreased compared to 35.2% same period last year
- Net Debt increased by $416 mln over the past reporting period (14.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.8% of market cap
- EV/EBITDA multiple is 16.6x compared to historical level (75th percentile) of 15.2x
- EV/Sales multiple is 5.8x

------------------------------------------------

2026-02-25

#reports #MATX

[Matson](https://eninvs.com/all.php?name=MATX) (Logistic services provider) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue -4.3% YoY (vs -8.5% in previous quarter and historical rate -5.9%)
- EBITDA +0.5% YoY (vs -27.8% in previous quarter and historical rate +2.7%)
- EBITDA margin 21.9% increased compared to 20.9% same period last year
- Net Debt decreased by $59 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 10x compared to historical level (75th percentile) of 10x
- EV/Sales multiple is 2x

------------------------------------------------

2026-02-25

#reports #LTH

[Life Time Group Holdings, Inc.](https://eninvs.com/all.php?name=LTH) (Leisure) reported for 2025 q4
(2026-02-24, Before Market Open):

- Revenue +12.4% YoY (vs +13.0% in previous quarter and historical rate +18.2%)
- EBITDA +31.8% YoY (vs +29.4% in previous quarter and historical rate +69.5%)
- EBITDA margin 27.8% increased compared to 23.7% same period last year
- Net Debt increased by $32 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) +$0 bln (positive), 0.6% of market cap
- EV/EBITDA multiple is 13.4x compared to historical level (75th percentile) of 19.6x
- EV/Sales multiple is 3.5x

------------------------------------------------

2026-02-25

#reports #KNSA

[Kiniksa Pharmaceuticals](https://eninvs.com/all.php?name=KNSA) (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195015)
(2026-02-24, Before Market Open):

- Revenue +64.2% YoY (vs +61.6% in previous quarter and historical rate +58.0%)
- EBITDA -169.7% YoY (vs +9700.0% in previous quarter and historical rate +35.3%)
- EBITDA margin -90.1% decreased compared to 212.2% same period last year
- Net Debt decreased by $63 mln over the past reporting period (2.0% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.4% of market cap
- EV/EBITDA multiple is 35.9x compared to historical level (75th percentile) of 31x
- EV/Sales multiple is 4.1x

------------------------------------------------

2026-02-25

#reports #KDP

[Keurig Dr Pepper](https://eninvs.com/all.php?name=KDP) (Soft drinks producer) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195047)
(2026-02-24, Before Market Open):

- Revenue +16.3% YoY (vs +2.3% in previous quarter and historical rate +7.6%)
- EBITDA +10.3% YoY (vs +0.3% in previous quarter and historical rate +11.1%)
- EBITDA margin 28.1% decreased compared to 29.6% same period last year
- Net Debt decreased by $13.9 bln since the start of the year (35.4% of market cap)
- FCF (LTM) +$0.6 bln (positive), 1.4% of market cap
- EV/EBITDA multiple is 9.6x compared to historical level (75th percentile) of 16.5x
- EV/Sales multiple is 2.6x

------------------------------------------------

2026-02-25

#reports #JAZZ

[Jazz Pharmaceuticals](https://eninvs.com/all.php?name=JAZZ) (Biotechnology) reported for [2025 q4](https://eninvs.com/press_release.php?source=sec&form_type=10&id=195046)
(2026-02-24, After Market Close):

- Revenue +10.1% YoY (vs +6.7% in previous quarter and historical rate +5.2%)
- EBITDA +17.8% YoY (vs -75.7% in previous quarter and historical rate -8.5%)
- EBITDA margin 35.4% increased compared to 33.1% same period last year
- Net Debt decreased by $402 mln over the past reporting period (3.9% of market cap)
- FCF (LTM) -$0.2 bln (negative), 2.1% of market cap
- EV/Sales multiple is 3.1x

------------------------------------------------

2026-02-25

#reports #IPAR

[Inter Parfums](https://eninvs.com/all.php?name=IPAR) (Perfume manufacturer) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +17.3% YoY (vs +15.5% in previous quarter and historical rate +19.4%)
- EBITDA +21.7% YoY (vs +18.5% in previous quarter and historical rate +21.3%)
- EBITDA margin 7.3% increased compared to 7.0% same period last year
- Net Debt decreased by $27 mln over the past reporting period (0.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.7% of market cap
- EV/EBITDA multiple is 11.6x compared to historical level (75th percentile) of 16.4x
- EV/Sales multiple is 2.2x

------------------------------------------------

2026-02-25

#reports #INGN

[Inogen](https://eninvs.com/all.php?name=INGN) (Medical products manufacturer) reported for 2025 q4
(2026-02-24, After Market Close):

- Revenue +2.5% YoY (vs +3.4% in previous quarter and historical rate -1.9%)
- EBITDA margin -4.9% increased compared to -7.5% same period last year
- Net Debt increased by $3 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) +$0 bln (positive), 8.0% of market cap
- EV/Sales multiple is 0.1x

Switch to company model in classical logic    *